Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GODAVARI DRU vs MYLAN (US) - Comparison Results

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 GODAVARI DRU   MYLAN
EQUITY SHARE DATA
    GODAVARI DRU
Mar-23
MYLAN
Dec-18
GODAVARI DRU/
MYLAN
5-Yr Chart
Click to enlarge
High Rs1023,969-   
Low Rs522,185-   
Sales per share (Unadj.) Rs212.01,826.5-  
Earnings per share (Unadj.) Rs5.049.6-  
Cash flow per share (Unadj.) Rs7.6391.6-  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs44.41,975.9-  
Shares outstanding (eoy) m7.53514.50-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.41.7 21.6%   
Avg P/E ratio x15.362.0 24.7%  
P/CF ratio (eoy) x10.17.9 128.8%  
Price / Book Value ratio x1.71.6 111.4%  
Dividend payout %00-   
Avg Mkt Cap Rs m5801,583,163 0.0%   
No. of employees `000NA35.0 0.0%   
Total wages/salary Rs m480-   
Avg. sales/employee Rs Th026,849.2-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0729.1-  
INCOME DATA
Net Sales Rs m1,596939,722 0.2%  
Other income Rs m70-   
Total revenues Rs m1,603939,722 0.2%   
Gross profit Rs m102243,165 0.0%  
Depreciation Rs m19175,953 0.0%   
Interest Rs m3945,197 0.1%   
Profit before tax Rs m4922,015 0.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m11-3,502 -0.3%   
Profit after tax Rs m3825,517 0.1%  
Gross profit margin %6.425.9 24.6%  
Effective tax rate %23.3-15.9 -146.3%   
Net profit margin %2.42.7 87.3%  
BALANCE SHEET DATA
Current assets Rs m870524,740 0.2%   
Current liabilities Rs m737382,593 0.2%   
Net working cap to sales %8.315.1 55.1%  
Current ratio x1.21.4 86.1%  
Inventory Days Days184 1.2%  
Debtors Days Days1,32593 1,419.7%  
Net fixed assets Rs m344182,291 0.2%   
Share capital Rs m75500 15.1%   
"Free" reserves Rs m2590-   
Net worth Rs m3341,016,607 0.0%   
Long term debt Rs m1191,097,246 0.0%   
Total assets Rs m1,2142,726,936 0.0%  
Interest coverage x2.31.5 151.8%   
Debt to equity ratio x0.41.1 33.1%  
Sales to assets ratio x1.30.3 381.5%   
Return on assets %6.42.6 244.9%  
Return on equity %11.32.5 451.3%  
Return on capital %19.53.2 614.4%  
Exports to sales %0.40-   
Imports to sales %60.30-   
Net fx Rs m-9560-   
CASH FLOW
From Operations Rs m132195,274 0.1%  
From Investments Rs m-86-100,935 0.1%  
From Financial Activity Rs m-38-90,970 0.0%  
Net Cashflow Rs m81,618 0.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 83.39 Rs / USD

Compare GODAVARI DRU With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare GODAVARI DRU With: WINDLAS BIOTECH  SHELTER PHARMA  NGL FINE CHM  MARKSANS PHARMA.  AMRUTANJAN HEALTHCARE  



Today's Market

Sensex Today Trades Higher | Nifty Above 22,500 | BSE Tanks 17%, Yes Bank Jumps 5% Sensex Today Trades Higher | Nifty Above 22,500 | BSE Tanks 17%, Yes Bank Jumps 5%(10:30 am)

Asian stocks got off to a positive start on Monday ahead of the Federal Reserve's policy meeting later in the week.